Strategic Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$23K Sell
160
-100
-38% -$8.93K 0.04% 229
2022
Q2
$24K Hold
260
0.04% 246
2022
Q1
$21K Hold
260
0.03% 285
2021
Q4
$20K Sell
260
-280
-52% -$22.3K 0.03% 281
2021
Q3
$44K Buy
+540
New +$41.1K 0.06% 163

Other funds holding MRK

Strategic Asset Management's MRK Position: Q3 2022 in Review

Strategic Asset Management reduced its Merck (MRK) stake by 38% in Q3 2022, selling an estimated $8.93K and leaving 160 shares worth $23K. The position accounts for 0.04% of the portfolio, ranked #229.

Strategic Asset Management first reported a position in MRK in Q3 2021 and has held it in 5 quarters since. The position peaked at $44K in Q3 2021. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Strategic Asset Management held 160 shares of Merck worth $23K as of Q3 2022.
  • Strategic Asset Management sold 100 Merck shares in Q3 2022, an estimated $8.93K.
  • Merck made up 0.04% of Strategic Asset Management's portfolio in Q3 2022, its #229 holding.
  • Strategic Asset Management first reported a position in Merck in Q3 2021 and has held it in 5 quarters since.
  • Strategic Asset Management's Merck position peaked at $44K in Q3 2021.
  • 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Strategic Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.